Hybridomas and monoclonal antibodies which specifically bind human basic fibroblast growth factor
AssigneeTakeda Chemical Industries, Ltd.
InventorsMakoto Iwane, Tsutomu Kurokawa, Koichi Igarashi
Life of this patent
Estimating the term…
Abstract
A monoclonal antibody is produced from a cloned hybridoma, and the monoclonal antibody combines specifically with basic fibroblast growth factor (bFGF). Therefore, the monoclonal antibody can be advantageously used for assay reagents on bFGF or for purification of bFGF.
Claims6
A hybridoma selected from the group consisting of FERM BP-4678, FERM BP-4677, FERM BP-4679, and FERM BP-4680 and referred to as HbF12, HbF52, HbF78 and HbF98, respectively.
A monoclonal antibody, which specifically binds with human basic fibroblast growth factor, wherein the antibody belongs to the immunoglobulin class IgG, and wherein the antibody is selected from the group consisting of monoclonal antibody MoAb12, MoAb52, MoAb78, and MoAb98, which are produced by hybridoma FERM BP-4678, FERM BP-4677, FERM BP-4679, and FERM BP-4680, respectively.
The monoclonal antibody produced by hybridoma FERM-4678, which is MoAb12.
The monoclonal antibody produced by hybridoma FERM-4677, which is MoAb52.
The monoclonal antibody produced by hybridoma FERM-4679, which is MoAb78.
The monoclonal antibody produced by hybridoma FERM-4680, which is MoAb98.
Dependencies are inferred from the claim text.